文献速递肺外科心外重症与机械循环支持

体外膜氧合桥接时长对肺移植结局的影响

Impact of Extracorporeal Membrane Oxygenation Bridging Duration on Lung Transplant Outcomes.
PubMed 文献 · Ann Thorac Surg · 2024-05-11

本研究基于OPTN数据库回顾性分析2016至2020年间566例以VV-ECMO桥接至肺移植的成人患者,按桥接时长分为≤5天、6-10天、11-20天和>20天四组。结果显示桥接时间越长,等待名单死亡率越高,但移植后1年生存与ECMO时长无关。

要点

  • VV-ECMO桥接时长>5天者等待名单死亡风险显著高于≤5天者。
  • 桥接时长与移植后1年生存无显著关联。
  • 作者认为优先极早期移植可能改善该人群等待名单结局。

核心结论

  • 延长ECMO桥接时长与更差的等待名单死亡率相关,但不影响肺移植后生存。
  • 作者认为优先极早期移植可能改善该人群的等待名单结局。

研究设计与样本

  • 回顾性观察性研究,使用器官获取与移植网络(OPTN)数据库。
  • 纳入2016至2020年间列为肺移植候选且以VV-ECMO桥接的成人(年龄≥18岁)566例。
  • 按移植前ECMO时长分为4组:组1(≤5天)、组2(6-10天)、组3(11-20天)、组4(>20天)。
  • 等待名单生存采用Fine-Gray竞争风险模型分析,移植后生存采用Cox回归比较。

主要发现

  • 566例患者中位年龄54岁,男性占49%;组1、2、3、4分别有174例(31%)、124例(22%)、130例(23%)、138例(24%)。
  • 总体VV-ECMO中位时长为10天(四分位距1-211天),178例(31%)在等待名单期间死亡。
  • Fine-Gray模型中,与组1相比,组2(SHR 2.95;95%CI 1.63-5.35)、组3(SHR 3.96;95%CI 2.36-6.63)、组4(SHR 4.33;95%CI 2.59-7.22,均P<.001)等待名单死亡风险更高。
  • 388例接受移植的患者中,移植前ECMO时长与1年生存无显著关联(Cox回归)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We sought to characterize the association between venovenous extracorporeal membrane oxygenation (VV-ECMO) bridging duration and outcomes in patients listed for lung transplantation. METHODS: A retrospective observational study was conducted using the Organ Procurement and Transplantation Network (OPTN) database to identify adults (aged ≥18 years) who were listed for lung transplantation between 2016 and 2020 and were bridged with VV-ECMO. Patients were then stratified into groups, determined by risk inflection points, depending on the amount of time spent on pretransplant ECMO: group 1 (≤5 days), group 2 (6-10 days), group 3 (11-20 days), and group 4 (>20 days). Waiting list survival between groups was analyzed using Fine-Gray competing risk models. Posttransplant survival was compared using Cox regression. RESULTS: Of 566 eligible VV-ECMO bridge-to-lung-transplant patients (median age, 54 years, 49% men), 174 (31%), 124 (22%), 130 (23%), and 138 (24%) were categorized as groups 1, 2, 3, and 4, respectively. Overall, median duration of VV-ECMO was 10 days (interquartile range, 1-211 days), and 178 patients (31%) died on the waiting list. In the Fine-Gray model, compared with group 1, patients bridged with longer ECMO durations in group 2 (subdistribution hazard ratio [SHR], 2.95; 95% CI, 1.63-5.35), group 3 (SHR, 3.96; 95% CI, 2.36-6.63), and group 4 (SHR, 4.33; 95% CI, 2.59-7.22, all P < .001) were more likely to die on the waiting list. Of 388 patients receiving a transplant, pretransplant ECMO duration was not associated with 1-year survival in Cox regression. CONCLUSIONS: Prolonged duration of ECMO bridging was associated with worse waiting list mortality but did not impact survival after lung transplant. Prioritization of very early transplantation may improve waiting list outcomes in this population.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Shou BL, Kalra A, Zhou AL, et al. Impact of Extracorporeal Membrane Oxygenation Bridging Duration on Lung Transplant Outcomes. Ann Thorac Surg. 2024. PMID: 38740080. doi:10.1016/j.athoracsur.2024.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。